You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-MET (MET) Antibodies

Full name:
anti-Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Antibodies (MET)
On www.antibodies-online.com are 0 Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) (MET) Antibodies from different suppliers available. Additionally we are shipping MET Kits (1) and many more products for this protein. A total of 1 MET products are currently listed.
Synonyms:
AUTS9, c-met, HGF, HGFR, MET, RCCP2
list all antibodies Gene Name GeneID UniProt
Anti-Rat MET MET 24553 P97523
Anti-Human MET MET 4233 P08581

Show all synonyms

More Antibodies against MET Interaction Partners

Human Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) (MET) interaction partners

  1. Finally, we showed cell proliferation inhibition and cell migration suppression in H460 and H1299 cells after SIM (show SIM2 Antibodies)-89 treatment. In conclusion, SIM (show SIM2 Antibodies)-89 inhibits tumor cell proliferation, migration and HGF (show HGF Antibodies) autocrine, suggesting it's potential antitumor activity.

  2. our data provide evidence for the critical involvement of c-Met signaling in cholesterol and bile acids toxicity

  3. Data show that genes coding for epidermal growth factor receptor (EGFR) and hepatocyte growth factor receptor (c-MET) were directly downregulated by both microRNAs miR-1 and miR-206.

  4. Study provides evidence that AXL (show AXL Antibodies) and MET are associated with cell proliferation and metastasis in lung cancer, and the crosstalk between these receptors affects tumor progression.

  5. overexpression of HGF resulted in resistance to c-MET tyrosine kinase inhibitors through an autocrine manner in gastric cancer cells

  6. CMET overexpression and CMET amplification are commonly found in non-small cell lung cancer (NSCLC) brain metastases and may represent a promising therapeutic target.

  7. Study shows that MET was directly regulated by miR (show MLXIP Antibodies)-23b and miR (show MLXIP Antibodies)-27b. Moreover, downregulating the MET gene by use of siRNA significantly inhibited cell migration and invasion by oral squamous cell carcinoma cells.

  8. Activation of the HGF (show HGF Antibodies)-mediated MET pathway is involved in escape to selective VEGFR (show KDR Antibodies) inhibition in neuroblastoma (show ARHGEF16 Antibodies) suggesting combined inhibition of MET and VEGFR (show KDR Antibodies) signaling to reduce secondary resistance and enhanced invasiveness.

  9. miR (show MLXIP Antibodies)-27b was frequently downregulated in NSCLC tissues and cell lines and could inhibit the malignant phenotypes of NSCLC cells by directly targeting the MET oncogene (show RAB1A Antibodies). The identification of miR (show MLXIP Antibodies)-27b-mediated novel signaling pathways may help reveal the molecular mechanism underlying the development and malignant progression of this disease.

  10. Therefore, our findings suggested miR (show MLXIP Antibodies)-34a could modulate human gastric cancer(GC) cell Cisplatin sensitivity by regulation of cell proliferation and apoptosis via targeting MET, potentially benefiting human GC treatment in the future.

Cow (Bovine) Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) (MET) interaction partners

  1. possible cooperative role of the EGF (show EGF Antibodies) and HGF (show HGF Antibodies) pathways and indicate that cross-talk between their respective receptors may modulate mammary gland development in the cow

MET Antigen Profile

Antigen Summary

The proto-oncogene MET product is the hepatocyte growth factor receptor and encodes tyrosine-kinase activity. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor. Various mutations in the MET gene are associated with papillary renal carcinoma. Two transcript variants encoding different isoforms have been found for this gene.

Alternative names and synonyms associated with MET

  • met proto-oncogene (hepatocyte growth factor receptor) (MET) antibody
  • met proto-oncogene (Met) antibody
  • met proto-oncogene (MET) antibody
  • hepatocyte growth factor (hepapoietin A; scatter factor) (HGF) antibody
  • hepatocyte growth factor (HGF) antibody
  • hepatoCyte growth factor receptor (Tsp_05936) antibody
  • AUTS9 antibody
  • c-met antibody
  • HGF antibody
  • HGFR antibody
  • MET antibody
  • RCCP2 antibody

Protein level used designations for MET

HGF receptor , HGF/SF receptor , SF receptor , c-Met , hepatocyte growth factor receptor , met proto-oncogene tyrosine kinase , proto-oncogene c-Met , scatter factor receptor , tyrosine-protein kinase Met , HGF receptor c-Met , hepatocyte growth factor , hepatoCyte growth factor receptor , met proto-oncogene , Hepatocyte growth factor receptor , hepatocyte growth factor receptor-like , Proto-oncogene c-Met , Scatter factor receptor , Tyrosine-protein kinase Met

GENE ID SPECIES
100126565 Oryctolagus cuniculus
24553 Rattus norvegicus
4233 Homo sapiens
280855 Bos taurus
403438 Canis lupus familiaris
443075 Ovis aries
463671 Pan troglodytes
493669 Felis catus
708316 Macaca mulatta
10911086 Trichinella spiralis
100126669 Papio anubis
100137030 Pongo abelii
100137502 Ornithorhynchus anatinus
100408551 Callithrix jacchus
Did you look for something else?